Clostridium difficile infection (CDI) is a common complication of IBD and is associated with disease flare-ups and adverse outcomes. Low levels of serum albumin and haemoglobin alongside high concentrations of serum creatinine predict the need for surgery and risk of death associated with CDI in patients with IBD.
This is a preview of subscription content, log in via an institution to check access.
References
Khanna, S. & Pardi D. S. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert Rev. Gastroenterol. Hepatol. 4, 409–416 (2010).
Khanna, S. et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am. J. Gastroenterol. 107, 89–95 (2011).
Ananthakrishnan, A. N., McGinley, E. L. & Binion, D. G. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 57, 205–210 (2008).
Ananthakrishnan, A. N. et al. Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease. Aliment. Pharmacol. Ther. 35, 789–795 (2012).
Nguyen, G. C., Kaplan, G. G., Harris, M. L. & Brant, S. R. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am. J. Gastroenterol. 103, 1443–1450 (2008).
Ananthakrishnan, A. N., McGinley, E. L., Saeian, K. & Binion, D. G. Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 17, 976–983 (2011).
Issa, M. et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 5, 345–351 (2007).
Lungulescu, O. A., Cao, W., Gatskevich, E., Tlhabano, L. & Stratidis, J. G. CSI: a severity index for Clostridium difficile infection at the time of admission. J. Hosp. Infect. 79, 151–154 (2011).
Ben-Horin, S. et al. Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection. Clin. Gastroenterol. Hepatol. 7, 981–987 (2009).
Zar, F. A., Bakkanagari, S. R., Moorthi, K. M. & Davis, M. B. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin. Infect. Dis. 45, 302–307 (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
S. Khanna declares no competing interests. D. S. Pardi has acted as a consultant for Optimer Pharmaceuticals.
Rights and permissions
About this article
Cite this article
Khanna, S., Pardi, D. Poor outcomes after Clostridium difficile infection in IBD. Nat Rev Gastroenterol Hepatol 9, 307–308 (2012). https://doi.org/10.1038/nrgastro.2012.87
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2012.87
- Springer Nature Limited
This article is cited by
-
Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD
Digestive Diseases and Sciences (2021)
-
Pancreatic disease patients are at higher risk for Clostridium difficile infection compared to those with other co-morbidities
Gut Pathogens (2019)
-
Clostridium difficile infection: Updates in management
Indian Journal of Gastroenterology (2017)
-
Uncovering the composition of microbial community structure and metagenomics among three gut locations in pigs with distinct fatness
Scientific Reports (2016)
-
Clostridium Difficile Infection from a Surgical Perspective
Journal of Gastrointestinal Surgery (2015)